Time Course of Treatment for Primary Enuresis With Overactive Bladder
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To characterize the course of treatment for nonmonosymptomatic enuresis with overactive bladder (OAB) in a real clinical setting. Methods: Data from 111 OAB patients with moderate to severe enuresis were analyzed. The baseline analysis included a questionnaire, voiding diary, uroflowmetry with postvoid residual urine measurement, and plain abdominal radiography of the kidneys, ureters, and bladder (KUB). Following standard urotherapy for 1 month, anticholinergic medication was administered with or without laxatives. Desmopressin was added if there was a partial response to OAB. Patients were followed every 3 months to evaluate the status of OAB and enuresis. Multivariate analysis was performed to identify predictors associated with the lack of complete response (CR) in enuresis at 12 months. Results: Following 12 months of treatment, 64% and 88% of patients experienced at least partial response in enuresis and OAB, respectively. Urgency improved more quickly than enuresis, supporting the need to address daytime symptoms before enuresis. Seventy-nine patients (71%) had fecal impaction on KUB and/or subjective constipation. The combination of anticholinergics with either laxatives or desmopressin fared better than anticholinergics alone. Daytime incontinence and anticholinergics- only treatment were associated with a lack of CR during 12 months of treatment. Conclusions: The data confirmed the validity of addressing OAB before treating enuresis. The results of this study also highlight the need to address fecal impaction. Patients should be counseled about the need for a prolonged course of treatment before starting treatment. Anticholinergics should be accompanied with either desmopressin or laxatives for better control of enuresis.
Abstract
Purpose: To characterize the course of treatment for nonmonosymptomatic enuresis with overactive bladder (OAB) in a real clinical setting. Methods: Data from 111 OAB patients with moderate to severe enuresis were analyzed. The baseline analysis included a questionnaire, voiding diary, uroflowmetry with postvoid residual urine measurement, and plain abdominal radiography of the kidneys, ureters, and bladder (KUB). Following standard urotherapy for 1 month, anticholinergic medication was administered with or without laxatives. Desmopressin was added if there was a partial response to OAB. Patients were followed every 3 months to evaluate the status of OAB and enuresis. Multivariate analysis was performed to identify predictors associated with the lack of complete response (CR) in enuresis at 12 months. Results: Following 12 months of treatment, 64% and 88% of patients experienced at least partial response in enuresis and OAB, respectively. Urgency improved more quickly than enuresis, supporting the need to address daytime symptoms before enuresis. Seventy-nine patients (71%) had fecal impaction on KUB and/or subjective constipation. The combination of anticholinergics with either laxatives or desmopressin fared better than anticholinergics alone. Daytime incontinence and anticholinergics- only treatment were associated with a lack of CR during 12 months of treatment. Conclusions: The data confirmed the validity of addressing OAB before treating enuresis. The results of this study also highlight the need to address fecal impaction. Patients should be counseled about the need for a prolonged course of treatment before starting treatment. Anticholinergics should be accompanied with either desmopressin or laxatives for better control of enuresis.
참고문헌 (20)
- Neveus T, "Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children's Continence Society", J Urol, 183, pp.441~447 (2010)[DOI]
- Franco I, "Evaluation and treatment of nonmonosymptomatic nocturnal enuresis: a standardization document from the International Children's Continence Society", J Pediatr Urol, 9, pp.234~243 (2013)[DOI]
- Vande Walle J, "Practical consensus guidelines for the management of enuresis", Eur J Pediatr, 171, pp.971~983 (2012)[DOI]
- Marks A, "Definition of reliable, objective criteria by abdominal radiography to identify occult constipation in children with lower urinary tract symptoms", J Urol, 189, pp.1519~1523 (2013)[DOI]
- McGrath KH, "The frequency of constipation in children with nocturnal enuresis: a comparison with parental reporting", J Paediatr Child Health, 44, pp.19~27 (2008)
- Franco I, "Overactive bladder in children. Part 1: Pathophysiology", J Urol, 178(3 Pt 1), pp.761~768 (2007)[DOI]
- Berkenwald A, "Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis", J Pediatr Urol, 12, pp.220.e1~220.e6 (2016)[DOI]
- Curran MJ, "The overactive bladder in childhood: long-term results with conservative management", J Urol, 163, pp.574~577 (2000)[DOI]
- Hoebeke P, "Solifenacin for therapy resistant overactive bladder", J Urol, 182(4 Suppl), pp.2040~2044 (2009)[DOI]
- Vermandel A, "Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity", BJU Int, 96, pp.629~633 (2005)[DOI]
- Rittig N, "Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients", Neurourol Urodyn, 33, pp.475~481 (2014)[DOI]
- Austin PF, "The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children's Continence Society", J Urol, 191, pp.1863~1865 (2014)[DOI]
- Akbal C, "Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population", J Urol, 173, pp.969~973 (2005)[DOI]
- Rasquin A, "Childhood functional gastrointestinal disorders: child", adolescent, 2006, pp.130, 1527~1537
- Alloussi SH, "Desmopressin treatment regimens in monosymptomatic and nonmonosymptomatic enuresis: a review from a clinical perspective", J Pediatr Urol, 7, pp.10~20 (2011)[DOI]
- Loening-Baucke V, "Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood", Pediatrics, 100(2 Pt 1), pp.228~232 (1997)[DOI]
- Bush NC, "Randomized, double-blind, placebo-controlled trial of polyethylene glycol (<TEX>$MiraLAX^{(R)}$<", TEX>) for urinary urge symptoms, 2013, pp.9, 597~604
- Van Batavia JP, "Use of non-invasive uroflowmetry with simultaneous electromyography to monitor patient response to treatment for lower urinary tract conditions", J Pediatr Urol, 10, pp.532~537 (2014)[DOI]
- Ebiloglu T, "The biofeedback treatment for non-monosymptomatic enuresis nocturna", Neurourol Urodyn, 35, pp.58~61 (2016)[DOI]
- Hoffmann A, "Predictors of outcome in children and adolescents with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation", J Pediatr Urol, 14, pp.54~ (2018)